Meconium Ileus

Abstract

Cystic fibrosis is one of the most common inheritable traits in Caucasians. Meconium ileus and its potential complications are the most likely reasons that these patients will need surgical care. Surgical intervention is usually needed in the neonatal period but may also be required later in life. This article discusses the various ways cystic fibrosis can affect the gastrointestinal tract. Both the operative and nonoperative management of complicated and uncomplicated meconium ileus are discussed in the neonatal period as well as long-term issues, such as distal intestinal obstructive syndrome, fibrosing colonopathy, and rectal prolapse, all of which may be seen in older children and adults.

Keywords

meconium ileus - cystic fibrosis - cystic fibrosis transmembrane conductance regulator - distal intestinal obstruction syndrome - epithelial sodium channels - fibrosing colonopathy - rectal prolapse - newborn intestinal obstruction

• References

• 1 Wilcken B, Wiley V, Sherry G, Bayliss U. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediatr 1995; 127 (06) 965-970
• 2 Kleven DT, McCudden CR, Willis MS. Cystic fibrosis: newborn screening in America. MLO Med Lab Obs 2008; 40 (07) 16-18 , 22, 24–27
• 3 Kopp BT, Nicholson L, Paul G, Tobias J, Ramanathan C, Hayes Jr D. Geographic variations in cystic fibrosis: an analysis of the U.S. CF Foundation Registry. Pediatr Pulmonol 2015; 50 (08) 754-762
• 4 Feuchtbaum L, Carter J, Dowray S, Currier RJ, Lorey F. Birth prevalence of disorders detectable through newborn screening by race/ethnicity. Genet Med 2012; 14 (11) 937-945
• 5 Sykes J, Stanojevic S, Goss CH. , et al. A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts. J Clin Epidemiol 2016; 70: 206-213
• 6 Viviani L, Bossi A, Assael BM. ; Italian Registry for Cystic Fibrosis Collaborative Group. Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age. J Cyst Fibros 2011; 10 (05) 313-317
• 7 Chaudry G, Navarro OM, Levine DS, Oudjhane K. Abdominal manifestations of cystic fibrosis in children. Pediatr Radiol 2006; 36 (03) 233-240
• 8 Riordan JR, Rommens JM, Kerem B. , et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245 (4922): 1066-1073
• 9 Spoonhower KA, Davis PB. Epidemiology of cystic fibrosis. Clin Chest Med 2016; 37 (01) 1-8
• 10 Boczar M, Sawicka E, Zybert K. Meconium ileus in newborns with cystic fibrosis - results of treatment in the group of patients operated on in the years 2000-2014. Dev Period Med 2015; 19 (01) 32-40
• 11 O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373 (9678): 1891-1904
• 12 Lavelle LP, McEvoy SH, Ni Mhurchu E. , et al. Cystic fibrosis below the diaphragm: abdominal findings in adult patients. Radiographics 2015; 35 (03) 680-695
• 13 Carlyle BE, Borowitz DS, Glick PL. A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon. J Pediatr Surg 2012; 47 (04) 772-781
• 14 Veyrac C, Baud C, Prodhomme O, Saguintaah M, Couture A. US assessment of neonatal bowel (necrotizing enterocolitis excluded). Pediatr Radiol 2012; 42 (Suppl. 01) S107-S114
• 15 Jackson CR, Orford J, Minutillo C, Dickinson JE. Dilated and echogenic fetal bowel and postnatal outcomes: a surgical perspective. Case series and literature review. Eur J Pediatr Surg 2010; 20 (03) 191-193
• 16 Carroll AG, Kavanagh RG, Ni Leidhin C, Cullinan NM, Lavelle LP, Malone DE. Comparative effectiveness of imaging modalities for the diagnosis of intestinal obstruction in neonates and infants: a critically appraised topic. Acad Radiol 2016; 23 (05) 559-568
• 17 Johnson JA, Bush A, Buchdahl R. Does presenting with meconium ileus affect the prognosis of children with cystic fibrosis?. Pediatr Pulmonol 2010; 45 (10) 951-958
• 18 Kappler M, Feilcke M, Schröter C, Kraxner A, Griese M. Long-term pulmonary outcome after meconium ileus in cystic fibrosis. Pediatr Pulmonol 2009; 44 (12) 1201-1206
• 19 Efrati O, Nir J, Fraser D. , et al. Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli multicenter study. J Pediatr Gastroenterol Nutr 2010; 50 (02) 173-178
• 20 Munck A, Gérardin M, Alberti C. , et al. Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study. J Pediatr Surg 2006; 41 (09) 1556-1560
• 21 Li Z, Lai HJ, Kosorok MR. , et al. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatr Pulmonol 2004; 38 (04) 277-284
• 22 Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 2004; 159 (06) 537-546
• 23 Kelly T, Buxbaum J. Gastrointestinal manifestations of cystic fibrosis. Dig Dis Sci 2015; 60 (07) 1903-1913
• 24 Mak GZ, Harberg FJ, Hiatt P, Deaton A, Calhoon R, Brandt ML. T-tube ileostomy for meconium ileus: four decades of experience. J Pediatr Surg 2000; 35 (02) 349-352
• 25 O'Neill Jr JA, Grosfeld JL, Boles Jr ET, Clatworthy Jr HW. Surgical treatment of meconium ileus. Am J Surg 1970; 119 (01) 99-105
• 26 Escobar MA, Grosfeld JL, Burdick JJ. , et al. Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes. Surgery 2005; 138 (04) 560-571 , discussion 571–572
• 27 Fitzgerald R, Conlon K. Use of the appendix stump in the treatment of meconium ileus. J Pediatr Surg 1989; 24 (09) 899-900
• 28 Jawaheer J, Khalil B, Plummer T. , et al. Primary resection and anastomosis for complicated meconium ileus: a safe procedure?. Pediatr Surg Int 2007; 23 (11) 1091-1093
• 29 Hill JT, Snyder Jr WH, Pollock WF. Management of complicated meconium ileus. Am J Surg 1964; 108: 233-238
• 30 Farrelly PJ, Charlesworth C, Lee S, Southern KW, Baillie CT. Gastrointestinal surgery in cystic fibrosis: a 20-year review. J Pediatr Surg 2014; 49 (02) 280-283
• 31 Houwen RH, van der Doef HP, Sermet I. , et al; ESPGHAN Cystic Fibrosis Working Group. Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 2010; 50 (01) 38-42
• 32 Borowitz D, Gelfond D. Intestinal complications of cystic fibrosis. Curr Opin Pulm Med 2013; 19 (06) 676-680
• 33 Jackson R, Pencharz PB. Transition of care between paediatric and adult gastroenterology. Cystic fibrosis. Best Pract Res Clin Gastroenterol 2003; 17 (02) 213-235
• 34 Dray X, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol 2004; 2 (06) 498-503
• 35 Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav 2008; 95 (03) 271-281
• 36 Colombo C, Ellemunter H, Houwen R, Munck A. Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros 2011; 10 Suppl 2: S24-S28
• 37 van der Doef HP, Kokke FT, van der Ent CK, Houwen RH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep 2011; 13 (03) 265-270
• 38 Morton JR, Ansari N, Glanville AR, Meagher AP, Lord RV. Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation. J Gastrointest Surg 2009; 13 (08) 1448-1453
• 39 Lavie M, Manovitz T, Vilozni D. , et al. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol 2015; 21 (01) 318-325
• 40 Siafakas C, Vottler TP, Andersen JM. Rectal prolapse in pediatrics. Clin Pediatr (Phila) 1999; 38 (02) 63-72
• 41 Kopel FB. Gastrointestinal manifestations of cystic fibrosis. Gastroenterology 1972; 62 (03) 483-491
• 42 Stern RC, Izant Jr RJ, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of rectal prolapse in cystic fibrosis. Gastroenterology 1982; 82 (04) 707-710
• 43 Pawel BR, de Chadarévian JP, Franco ME. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. Hum Pathol 1997; 28 (04) 395-399
• 44 Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343 (8889): 85-86
• 45 Reichard KW, Vinocur CD, Franco M. , et al. Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg 1997; 32 (02) 237-241 , discussion 241–242
• 46 Smyth RL, Ashby D, O'Hea U. , et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346 (8985): 1247-1251
• 47 Bakowski MT, Prescott P. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis. Pharmacoepidemiol Drug Saf 1997; 6 (05) 347-358
• 48 FitzSimmons SC, Burkhart GA, Borowitz D. , et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997; 336 (18) 1283-1289
• 49 Serban DE, Florescu P, Miu N. Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation. J Pediatr Gastroenterol Nutr 2002; 35 (03) 356-359
• 50 Lee J, Ip W, Durie P. Is fibrosing colonopathy an immune mediated disease?. Arch Dis Child 1997; 77 (01) 66-70
• 51 Schwarzenberg SJ, Wielinski CL, Shamieh I. , et al. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995; 127 (04) 565-570